who should not use glp-1 Weight Loss Medications: What You Need to Know GLP-1 Medications for Weight Loss:

Other factors, such as sufficient protein intake, sleep quality, age, and the rate of weight loss, also influence how much muscle mass you may retain while taking a GLP-1, Pinto says

A comprehensive study analyzed the efficacy of various therapeutics for ME/CFS and Long COVID across thousands of patients

Tirzepatide is an FDA-approved drug with completed Phase 3 obesity trials, while cagrilintide is investigational, with monotherapy data only through Phase 2 and its strongest results coming from the CagriSema combination

Statements Data availability statement The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author

This historical data serves as the foundation for our database